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Abstract
Important advances have been made in the immunodiagnosis of tuberculosis (TB) based on the detection of Mycobacterium
tuberculosis (MTB)-specific T cells. However, the sensitivity and specificity of the immunological approach are relatively low
because there are no specific markers for antigen-specific Th cells, and some of the Th cells that do not produce cytokines can
be overlooked using this approach. In this study, we found that MTB-specific peptides of ESAT-6/CFP-10 can stimulate the
expression of CD40L specifically in CD4
+ T cells but not other cells from pleural fluid cells (PFCs) in patients with tuberculous
pleurisy (TBP). CD4
+CD40L
+ but not CD4
+CD40L
2 T cells express IFN-c, IL-2, TNF-a, IL-17 or IL-22 after stimulation with MTB-
specific peptides. In addition, CD4
+CD40L
+ T cells were found to be mostly polyfunctional T cells that simultaneously produce
IFN-c, IL-2 and TNF-a and display an effector or effector memory phenotype (CD45RA
2CD45RO
+CCR7
2CD62L
2ICOS
2). To
determine the specificity of CD4
+CD40L
+ T cells, we incubated PFCs with ESTA-6/CFP-10 peptides and sorted live CD4
+CD40L
+
and CD4
+CD40L
2 T cellsbyflow cytometry. Wefurther demonstrated thatsortedCD4
+CD40L
+,butnotCD4
+CD40L
2fractions,
principally produced IFN-c, IL-2, TNF-a, IL-17 and IL-22 following restimulation with ESTA-6/CFP-10 peptides. Taken together,
our data indicate that the expression of CD40L on MTB-specific CD4
+ T cells could be a good marker for the evaluation and
isolation of MTB-specific Th cells and might also be useful in the diagnosis of TB.
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Introduction
Tuberculous pleurisy (TBP)—the second most frequent mani-
festation of extrapulmonary tuberculosis (TB) after lymph node
TB—is restricted to the pleural cavity, which contains numerous
immunocompetent cells [1]. TBP resolves spontaneously in some
patients without treatment. Thus, TBP is thought to be a good
model system for studying the protective immune response at the
site of infection [2]. It is well recognized that cell-mediated
immunity is required for an effective response to Mycobacterium
tuberculosis (MTB) infection. In MTB infection, the Th1 response
has been shown to be protective [3]. IFN-c, a Th1 type cytokine
that is the most important factor for macrophage activation, is
essential for TB immunity [4]. Although some studies have shown
that IL-4 is not essential for the development of a protective
immune response to MTB [5,6], Sugawara et al. showed that IL-4
is required for proper defense against TB infection [7]. In addition,
Th17 cells can recruit granulocytes to the site of MTB persistence
to produce inflammation [8]; these cells seem to play an important
role in the early development of protective immunity in the lungs
[8,9,10]. IL-22-producing CD4
+ T cells are distinct from Th1 and
Th17 cells and have also been shown to play important roles in the
human immune response to mycobacteria [11].
Currently, the analysis and isolation of distinct antigen-specific
Th cells relies on the detection of cytokines that are produced by
these cells or the rare selection of specific multimers of peptide and
major histocompatibility complex class II molecules. However,
using cytokines to detect Th cells could bias the measurement of
the frequencies of antigen-specific Th cells. Moreover, antigen-
specific T cells that do not produce cytokines would be missed
using this approach [12,13,14,15]. Previous work has shown that
the expression of CD40L (CD154) can be used to detect Th cells
that are specific for defined antigens and to isolate viable Th cells
for further study [16,17]. CD40L is expressed by antigen-specific
T cells following activation and could provide costimulatory
signals to APCs (antigen-presenting cells) [18] and B cells [19,20].
Because CD40L is only transiently expressed on the cell surface, it
is difficult to detect [21,22]. A modified assay has been developed
that stabilizes the intracellular expression of CD40L with the
secretion inhibitor Brefeldin A (BFA) [16]. Another assay uses the
detection antibody and a protein transport inhibitor, monensin, to
detect surface expression of CD40L directly [17].
In the present study, we demonstrated for the first time that the
expression of CD40L on MTB-specific Th cells can be a good
marker for the isolation of Th1, Th17 and Th22 cells.
Furthermore, we found that CD40L expression on CD4
+ T cells
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e20165can be used to diagnose TB and for functional studies of MTB-
specific Th cells.
Results
MTB-specific peptides induce the expression of CD40L by
CD4
+ T cells
We first investigated the specificity of CD40L expression by
CD4
+ T cells. Pleural fluid cells (PFCs) from tuberculous pleurisy
(TBP) or PBMCs from healthy individuals were stimulated in the
presence or absence of MTB-specific peptides (ESAT-6/CFP-10).
As expected, we found that unstimulated cells do not express
CD40L. In addition, CD40L expression was not detected in either
CD4
+ or CD8
+ T cells of PBMCs following stimulation with ESAT-
6/CFP-10 peptides (Fig. 1A). In contrast, CD40L expression could
be clearly detected in CD4
+ but not CD8
+ T cells of PFCs following
stimulation with ESAT-6/CFP-10 peptides (Fig. 1B). Statistical
results indicated that significantly higher expression of CD40L by
CD4
+ T cells was induced in PFCs than PBMCs (data not shown),
suggesting that CD40L expression is induced on antigen-specific
CD4
+T cells. However, no detectable expression of CD40L by
CD8
+ T cells from either PBMCs or PFCs was observed following
either antigen-specific or polyclonal stimulation with anti-CD3 plus
anti-CD28 (Fig. 1), suggesting that the expression of CD40L is
predominantly restricted to CD4
+ T cells.
CD4
+CD40L
+ T cells primarily express IFN-c, IL-2, TNF-a,
IL-17 and IL-22
To confirm that CD40L identifies MTB-specific CD4
+T cells,
we assessed the cytokine production by CD4
+CD40L
+ and
CD4
+CD40L
2 T cells. From the CD4
+ T cells analyzed, only
the cells expressing CD40L produced IFN-c, IL-2, TNF-a, IL-17
or IL-22 (Fig. 2A), suggesting that the expression of CD40L
identifies the majority of the responding Th cells. Moreover,
considerably higher levels of Th1 cytokines (IFN-c, IL-2 and TNF-
a) were found to be expressed by CD4
+CD40L
+ T cells, suggesting
that the majority of CD4
+CD40L
+ T cells are Th1 cells. We
confirmed this idea by detecting the expression of T-bet, an
essential transcriptional factor in Th1 cells. We found that more
than 90% of CD4
+CD40L
+ T cells express T-bet (Fig. 2D). We
also measured the expression of Th2 cytokines and found that little
to no IL-4 or IL-10 is induced following stimulation with ESAT-6/
CFP-10 peptides (data not shown). We found that Th1 cytokine-
producing CD4
+CD40L
+ cells were significantly more abundant
than CD4
+CD40L
2 cells (Fig. 2B). Moreover, CD4
+CD40L
+ T
cells were found to produce significantly higher amounts of IL-17
Figure 1. M.tuberculosis (MTB)-specific expression of CD40L on CD4
+ and CD8
+ T cells from pleural fluid cells (PFCs) of tuberculous
pleurisy (TBP) and PBMCs from healthy individuals. PFCs from TBP and PBMCs from healthy donors were incubated for eight hours in the
presence of medium alone, ESAT-6/CFP-10 peptides with anti-CD28 plus anti-CD49d or anti-CD3 plus anti-CD28 monoclonal antibodies (mAbs).(A)
Expression of CD40L on CD4
+ and CD8
+ T cells in PFCs from TBP and (B) PBMCs from healthy donors were detected by FACS. Data shown are
representative of five independent experiments.
doi:10.1371/journal.pone.0020165.g001
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+CD40L
2 T cells. However, the cytokine
level was considerably lower than in Th1-cytokine-producing cells
(Fig. 2C), suggesting that natural MTB infection induces a mixed
Th-cell response characterized by Th1, Th17 and Th22 cells.
CD4
+CD40L
+ T cells are dominated by polyfunctional Th1
cells
We next analyzed the expression of CD40L by the Th1 cytokine
(IFN-c, IL-2 or TNF-a)-producing cells and the non-Th1
cytokine-producing CD4
+ T cells. We found that the CD4
+ T
cells that express at least one Th1 cytokine (IFN-c, IL-2 or TNF-a)
are mostly CD40L
+ (71.6462.44%, mean 6 SEM); cells that do
not express any of the measured Th1 cytokines are mostly
CD40L
2 (3.5061.39%, Fig. 3A, B). We then analyzed the
cytokine profiles of CD4
+CD40L
+ T cells by measuring the
production of IFN-c, IL-2 and TNF-a. We found that
CD4
+CD40L
+ T cells produce IFN-c, IL-2 and TNF-a, either
concurrently or individually (Fig. 3C). We defined the total Th1
response in the CD4
+CD40L
+ T cells as the percentage of T cells
expressing any combination of IFN-c, IL-2 or TNF-a. With this
metric, seven distinct functional populations could be delineated:
IFN-c/IL-2/TNF-a triple expressers, IFN-c/IL-2, IFN-c/TNF-a
or TNF-a/IL-2 double expressers or IFN-c, IL-2 or TNF-a single
expressers. Polyfunctional T cells that simultaneously produce
IFN-c, IL-2 and TNF-a (IFN-c/IL-2/TNF-a triple expressers)
were found to dominate the CD4
+CD40L
+ T cells. The
percentage of polyfunctional T cells was found to be considerably
higher than that of the other six subsets (Fig. 3D). The percentage
of double producers (15.53%) was found to be similar to the
percentage of single producers (15.60%, Fig. 3E).
CD4+CD40L+ T cells are mostly effector or effector
memory T cells
We next investigated the phenotype of CD4
+CD40L
+ Tc e l l sw i t h
respect to naı ¨ve/memory and activation markers. As shown in
Fig. 4A, CD4
+CD40L
+ T cells were found to be predominantly
CD45RO
+CD45RA
2, which are effector or memory cells. In
contrast, CD4
+CD40L
2 T cells contain a significantly higher
percentage of CD45RA
+ cells and a lower percentage of CD45RO
+
cells. We also found that CD4
+CD40L
+ T cells express significantly
lower levels of CD62L and CCR7 than CD4
+CD40L
2 Tc e l l s
(Fig. 4A). Because the expression of CD40L was found to be induced
following the activation of CD4
+ T cells, we also looked for the
expression of other activation markers, including CD69, CD25,
HLA-DR and the inducible costimulator (ICOS). A fraction of
CD4
+CD40L
+ T cells were found to express CD69 and HLA-DR
but not CD25. ICOS was found to be expressed in a small amount of
CD4
+CD40L
2 T cells but not in CD4
+CD40L
+ cells (Fig. 4B).
Figure 2. CD4
+CD40L
+ but not CD4
+CD40L
2 T cells express IFN-c, IL-2, TNF-a, IL-17 or IL-22 following MTB-specific stimulation. PFCs
were stimulated with ESAT-6/CFP10 peptides, anti-CD28 and anti-CD49d mAbs. CD4
+CD40L
+ and CD4
+CD40L
2 cells were gated.(A) CD4
+CD40L
+ but
not CD4
+CD40L
2 T cells express IFN-c, IL-2, TNF-a, IL-17 or IL-22. The numbers in the quadrants are the percentages of cells. (B) Ratio of IFN-c, IL-2,
TNF-a, (C) IL-17 and IL-22 expression by CD4
+CD40L
+ or CD4
+CD40L
2 cells. Results shown are the mean 6 SEM from 12 to 21 independent
experiments. *P,0.05; **P,0.01; ***P,0.001. (D) Histogram graph of T-bet expression by CD4
+CD40L
+ T cells. Filled histogram represents isotype
control staining and open histogram represents T-bet staining. Data shown are representative of five independent experiments.
doi:10.1371/journal.pone.0020165.g002
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We further investigated whether it would be possible to obtain
viable purified CD4
+CD40L
+ T cells after incubation with MTB-
specific peptides and a fluorescently labeled anti-CD40L monoclo-
nalantibodyand cell sorting withFACS.PFCswerestimulated with
ESAT-6/CFP-10 peptides in the presence of a fluorescently labeled
CD40L monoclonal antibody and monensin. CD4
+ T cells and
CD14
+ cells were purified with a positive microbead selection
(Fig. 5A). CD4
+CD40L
+ and CD4
+CD40L
2 T cells were then
isolated using flow cytometry (Fig. 5B). We then restimulated either
CD4
+CD40L
+ or CD4
+CD40L
2 T cells with CD14
+ cells (antigen-
presenting cells) in the presence of ESAT-6/CFP-10 peptides and
measured the production of cytokines. Notably, CD4
+CD40L
+ but
not CD4
+CD40L
2 fractions produced considerably higher levels of
IFN-c, IL-2 and TNF-a (Fig. 5C, D). Similarly, significantly higher
levels of IFN-c, IL-2 and TNF-a were detected in the supernatants
of CD4
+CD40L
+ fractions than inthose ofCD4
+CD40L
2 (Fig. 5E).
Wealsoassessed thelevels ofIL-4,IL-10,IL-17 and IL-22 inculture
supernatants. Although lowlevels of IL-17 and IL-22 were detected,
it is clear that the CD4
+CD40L
+ fractions were highly enriched for
both IL-17 and IL-22 compared with CD4
+CD40L
2 fractions
(Fig. 5E). IL-21, as well as the Th2 cytokines IL-4 and IL-10, was
not detectable in our co-culture system (data not shown). Thus, the
expression of CD40L can be used to identify the vast majority of
MTB-specific Th1, Th17 and Th22 cells.
Discussion
There is clinical and immunological data to suggest that TBP is
a good model for understanding protective immune mechanisms
against MTB at the site of infection [23]. It is well known that T
helper (Th) cells that target MTB are critical in TB prognosis [24].
Although it is well recognized that Th1 cells are essential in the
cell-mediated response to MTB, other T helper subsets also
participate in the cellular immune responses to MTB [11,25].
Understanding the roles for these Th cell subsets will be essential
for the evaluation of MTB-specific cellular immune responses and
for the immunodiagnosis of TB.
T cell IFN-c release assays (TIGRA) are more specific and
sensitive diagnostic tools for MTB infection than the tuberculin
skin test (TST) [26,27,28]. TIGRA measures IFN-c production by
mononuclear cells following stimulation with restricted antigens
that are absent from BCG or most non-tuberculous Mycobacteria
(NTM) [1]. Thus, TIGRA cannot be used to measure MTB-
specific Th cells that do not produce IFN-c following antigen
stimulation.
Figure 3. CD4
+CD40L
+ T cells express polyfunctional cytokines. PFCs were stimulated with ESAT-6/CFP-10 peptides, anti-CD28 and anti-
CD49d mAbs for eight hours. For detection of intracellular cytokines, anti-IFN-c, anti-IL-2 and anti-TNF-a monoclonal antibodies were labeled with the
same fluorescence. The staining of CD40L and cytokines of IFN-c/IL-2/TNF-a were conducted in one FACS tube.(A) Th1 cytokine (IFN-c, IL-2 or TNF-a)
producing and nonproducing cells were gated. The expression of CD40L was evaluated. (B) Summary of the CD40L expression data within Th1
cytokine producing and nonproducing cells. Horizontal lines represent mean 6 SEM. (C) CD4
+IFN-c
+ and CD4
+IFN-c
2 cells within CD4
+CD40L
+ T cells
were further gated, and the expression of IL-2 and TNF-a are shown. (D) The total antigen response within CD4
+CD40L
+ T cells was defined as the
number of cells expressing any combination of IFN-c, IL-2 or TNF-a. The average percentages for each subset are shown. (E) The percentages of cells
producing three cytokines (triple positive), two cytokines (double positive) or only one cytokine (single positive) within the total CD4
+CD40L
+ T cell
response. Data shown are the mean values from five independent experiments.
doi:10.1371/journal.pone.0020165.g003
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natural TB infection and the limitations of measuring antigen-
specific Th cells with cytokine production make the identification
of a marker to directly evaluate the entire repertoire of antigen-
specific Th cells an important research topic. In this study, we
found that CD40L expression on CD4
+ T cells is a good marker
for the evaluation of MTB-specific Th cells. This measurement
allows us to estimate the quantity, as well as quality, of MTB-
specific Th cells. We used intracellular staining to detect CD40L
expression with BFA [16], and we isolated viable CD4
+CD40L
+
cells using a fluorescently-labeled CD40L-specific antibody and
monensin treatment [17].
We showed that CD4
+CD40L
+ but not CD4
+CD40L
2 T cells
primarily express IFN-c, IL-2, TNF-a, IL-17 or IL-22 following
stimulation with MTB-specific ESAT-6/CFP-10 peptides. The
majority of CD4
+CD40L
+ T cells were found to be Th1 cells that
express IFN-c, IL-2, TNF-a and T-bet. Although the percentages
of IL-17 or IL-22-producing cells were relatively low as compared
with those that produce Th1 cytokines, CD4
+CD40L
+ cells were
found to highly express IL-17 and IL-22 compared with
CD4
+CD40L
2 T cells. In addition, we also assessed the expression
of CD40L and IFN-c by PFCs following stimulation with non-
MTB-specific antigen SARS-CoV S peptide 50 (STFFSTFKC-
YGVSATKL) or SARS-CoV S peptide 107 (NFSQILPDPLK-
PTKRSFI) and found that CD4
+ T cells did not express either
IFN-c or CD40L in response to SARS-CoV peptide. However,
PFCs from the same patients expressed CD40L and IFN-c
following stimulation with MTB-specific peptides of ESAT-6/
CFP-10. Therefore, we showed that MTB-specific Th cells are
primarily enriched with CD4
+CD40L
+ cells and that CD40L can
be a good marker to evaluate MTB-specific Th cells, irrespective of
the cytokine profile.
A number of studies in humans have shown that polyfunctional
T cells that secrete multiple cytokines may indeed mediate
protection against TB [29,30,31,32,33]. Importantly, we con-
firmed that CD4
+CD40L
+ cells are primarily dominated by
polyfunctional Th1 cells that can secrete three cytokines
simultaneously. Therefore, we believe that CD40L can be used
not only as a marker for MTB-specific Th cells but also as a highly
specific marker of polyfunctional Th cells. In other words, the
detection of CD4
+CD40L
+ cells could represent MTB-specific Th1
cells, and we could thus evaluate polyfunctional T cells without
Figure 4. CD4
+CD40L
+ and CD4
+CD40L
2T cells display different phenotypes. PFCs were stimulated with ESAT-6/CFP-10 peptides, anti-
CD28 and anti-CD49d mAbs. CD4
+CD40L
+ and CD4
+CD40L
2 T cells were gated. (A) The expression of CD45RA, CD45RO, CD62L, CCR7 and (B) the
expression of activation markers CD69, CD25, HLA-DR and ICOS by CD4
+CD40L
+ and CD4
+CD40L
2 T cells. One representative datapoint from five
independent experiments is shown.
doi:10.1371/journal.pone.0020165.g004
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PLoS ONE | www.plosone.org 6 May 2011 | Volume 6 | Issue 5 | e20165measuring all three cytokines simultaneously. CD4
+CD40L
+ T
cells display CD45RA
2CD45RO
+CCR7
2CD62L
2ICOS
2 effec-
tor or effector memory cells with the expression of some activation
markers, including CD69 and HLA-DR but not CD25 and ICOS.
Our results suggest that CD40L cannot be replaced by other
activation markers to evaluate antigen-specific CD4
+ T cells.
Moreover, these markers lack specificity, as they are also known to
be expressed by specialized T cell subsets (regulatory T cells) and
induced by cytokines [34,35,36].
Lastly, we incubated PFCs with ESAT-6/CFP-10 peptides
and fluorescently labeled anti-CD40L antibody and sorted
CD4
+CD40L
+ and CD4
+CD40L
2 T cells by flow cytometry. We
showed that sorted CD4
+CD40L
+ but not CD4
+CD40L
2 fractions
produce high levels of IFN-c, IL-2 and TNF-a following
restimulation with ESAT-6/CFP-10 peptides. This result is
consistent with those of our initial assay. We also demonstrated
that sorted CD4
+CD40L
+ fractions produce significantly higher
levels of IFN-c, IL-2, TNF-a, IL-17 and IL-22 but not Th2
cytokines (IL-4 and IL-10) compared with CD4
+CD40L
2 fractions.
These results demonstrate that the expression of CD40L on MTB-
specific CD4
+ T cells is a good marker for the evaluation of all T
helper subsets involved in TB infection. Our results further suggest
that distinct T helper cells are induced during natural MTB
infection and that these cells differ in their ability to provide
CD40L-mediated help from APC and B cells [10].
In conclusion, we showed that CD40L is more specific and
sensitive for the analysis and isolation of MTB-specific Th cells
than any other cytokine or activation molecule and CD40L
expression could be a valuable marker for the diagnosis of TB.
Materials and Methods
Study participants
A total of twenty-two patients with tuberculous pleurisy (10
females and 12 males, 23–71 years old) were recruited from the
Chest Hospital of Guangzhou, China. The diagnosis of pleural
effusion from TB etiology was based on the following criteria: (i)
M. tuberculosis on a pleural fluid smear (by Ziehl-Neelsen method);
(ii) pleural fluid or pleural biopsy specimens growing M. tuberculosis
on Lowenstein-Jensen medium; (iii) histological evidence of
caseating granuloma on biopsy specimens of pleural tissue with
positive staining for M. tuberculosis. The patients who had been
diagnosed with HIV, HBV, or HCV or that had a history of
autoimmune diseases were excluded from the study. Five healthy
volunteers were recruited from Sun Yat-sen University. Written
informed consent was obtained from all of the patients and healthy
donors. The study was approved by the Zhongshan School of
Medicine Review Board (Guangzhou, China).
Peptides, reagents and mAbs
To detect M. tuberculosis-specific responses, we selected six highly
immunogenic and largely HLA-DR-restricted peptides. Four were
derived from ESAT-6 and two from the CFP-10 protein of M.
tuberculosis. Synthetic peptides of 20 amino acids (aa) in length were
obtained from Shenzhen Hanyu manufacture, Shenzhen, China.
The sequences of the peptides are as follows: P1, ESAT-61–20
(MTEQQWNFAGIEAAASAIQG); P2, ESAT-631–50 (EGKQSL-
TKLAA AWGGSGSEA); P3, ESAT-661–80 (TATELNNALQN-
LARTISEAG); P4, ESAT-671–90 (NLARTISEAGQAMASTEG-
NV); P5, CFP-1051–70 (AQAAVVRFQEAANKQKQ ELD) and
P6, CFP-1071–90 (EISTNIRQAGVQYSRADEEQ). Purified anti-
CD28 (clone CD28.2) and anti-CD49d (clone 9F10) mAbs were
purchased from BD Biosciences (San Jose, CA). The following mAbs
were used for phenotypic, intracellular cytokine or transcription
factor analyses: CD62L-PE (Dreg56), CCR7-PE (3D12), TNF-a-
Pecy7 (MAb11), CD69-Pecy7 (FN50), CD45RA-FITC (L48),
CD45RO-FITC (UCHL1), CD25-FITC (M-A251), HLA-DR-PE
(L243 (G46-6)), T-bet-PE (O4-46), CD4-PerCP (L200), APC-IL-2
(MQ1-17H12). Isotype-matched control antibodies were purchased
from BD Biosciences (San Jose, CA, USA). CD27-APC (O323) was
obtained from Biolegend (San Diego, CA). IFN-c-FITC (45.15) was
bought from Beckman Coulter (Fullerton, CA). IL-17A-PE (eBio64-
CAP17) was purchased from eBioscience (Santiago, USA), and IL-
22-PE (142928) was purchased from R & D Systems (Minneapolis,
MN). Purified anti-CD3 and anti-CD28 mAbs were purchased from
BD Bioscience.
Preparation of PFCs and PBMCs
PFCs were isolated by first lysing erythrocytes with an
ammonium chloride solution and resuspending the pellet to a
final concentration of 2610
6 cells/mL in complete RPMI 1640
medium (Invitrogen, Grand Island, NY) supplemented with 10%
heat-inactivated fetal calf serum (FCS; HyClone, Logan, UT),
100 U/mL penicillin, 100 mg/mL streptomycin, 2 mM L-gluta-
mine, and 50 mM 2-mercaptoethanol. Peripheral blood mononu-
clear cells (PBMCs) were isolated by Ficoll-Hypaque gradient
centrifugation of heparinized venous blood obtained from healthy
individuals or TB patients.
Flow cytometry
Todetectintracellular cytokines andCD40L,cells were incubated
with 1 mg/mL peptides plus 1 mg/mL anti-CD28 and 1 mg/mL
anti-CD49d for 8 h in the presence of brefeldin A (BFA, 10 mg/mL;
Sigma-Aldrich, St Louis, MO). After stimulation, cells were washed
twice with PBS buffer containing 0.1% BSA and 0.05% sodium
azide. Thereafter, cells were incubated with the monoclonal Abs
(mAbs) for surface markers at 4uC in the dark for 30 min. The cells
werethenwashedtwiceandfixedin4%paraformaldehyde,followed
by permeabilization and stained for the intracellular cytokines and
CD40L in PBS buffer containing 0.1% saponin. For the analysis of
CD40L expression and Th1 cytokine-producing cells, we chose anti-
IFN-c, anti-IL-2 and anti-TNF-a monoclonal antibodies labeled
with the same fluorescence. Thereafter, we performed the staining of
CD40L and IFN-c/IL-2/TNF-a in one FACS tube. We could thus
analyze CD40L expression and IFN-c/IL-2/TNF-a expression in
one graph. Flow cytometry was performed using a FACSAria II (BD
Biosciences). Data were analyzed using FlowJo software (TreeStar,
San Carlos, CA).
Isolation of cell subsets
PFCs were stimulated with peptides in the presence of PE-
labeled anti-CD40L monoclonal antibody and Protein Transport
Figure 5. Isolation of viable CD4
+CD40L
+ and CD4
+CD40L
2 T cells. PFCs were stimulated with ESAT-6/CFP-10 peptides, anti-CD28 and anti-
CD49d mAbs in the presence of a fluorescently labeled anti-CD40L monoclonal antibody and monensin. CD4
+T cells were first isolated with
magnetic-beads. (A) The expression of CD40L within purified CD4
+ T cells was demonstrated, and (B) CD4
+CD40L
+ and CD4
+CD40L
2 T cells were
further sorted by flow cytometry. (C) Sorted CD4
+CD40L
+ or (D) CD4
+CD40L
2 T cells were co-cultured with purified CD14 cells independently in the
presence of ESAT-6/CFP-10 peptides. The intracellular expression of IFN-c, IL-2 or TNF-a by sorted CD4
+CD40L
+ and CD4
+CD40L
2 T cells was detected
by flow cytometry. (E) The amounts of IFN-c, IL-2, TNF-a, IL-17 and IL-22 were measured supernatants were measured using ELISA.
doi:10.1371/journal.pone.0020165.g005
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Thereafter, CD4
+ and CD14
+ cells were isolated from PFCs by
positive selection using anti-CD4 or anti-CD14 microbeads
(Miltenyi Biotec, Bergisch Gladbach, Germany). The isolation of
CD4
+CD40L
+ and CD4
+CD40L
2 cells was performed using
purified CD4
+ T cells on a FACSAria II high-speed cell sorter.
The purity of cells, as assessed by flow cytometry, exceeded 97%
for each cell subset. Purified CD4
+CD40L
+ or CD4
+CD40L
2 T
cells were co-cultured with purified CD14
+ cells (at ratio of 1:2) in
the presence of ESAT-6 and CFP-10 peptides. Cell-free
supernatants were collected, and IFN-c, IL-2, TNF-a, IL-4, IL-
10, IL-17 and IL-22 were detected with ELISA. The ELISA kit for
the detection of IFN-c, IL-2, TNF-a, IL-4 and IL-10 was
purchased from BD Bioscience Pharmingen. The ELISA kit for
IL-22 was purchased from R & D Systems. The IL-17 ELISA kit
was purchased from eBioscience. To detect intracellular cytokines,
cells were cultured for 8 hours, and then flow cytometry was
performed.
Statistical analysis
Wilcoxon matched pairs test (Two-tailed) was used to determine
the statistical differences between the groups using GraphPad
Prism software version 5. A value of p,0.05 was considered
statistically significant.
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